Nightingale Health Oyj
F:7XE
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.714
3.55
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| FI |
N
|
Nightingale Health Oyj
OMXH:HEALTH
|
114.8m EUR |
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
104.7B USD |
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
63.4B EUR |
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
74.2B USD |
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
27.2B EUR |
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
21.9B EUR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
20B USD |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
14.5B USD |
Loading...
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR |
Loading...
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
7.6B USD |
Loading...
|
Market Distribution
| Min | -49 731.8% |
| 30th Percentile | -0.5% |
| Median | 2.3% |
| 70th Percentile | 7.2% |
| Max | 266.5% |
Other Profitability Ratios
Nightingale Health Oyj
Glance View
Nightingale Health Oyj engages in the development of health data platform for healthcare service providers. The company is headquartered in Helsinki, Etela-Suomen and currently employs 77 full-time employees. The company went IPO on 2021-03-19. The blood analysis technology developed by Nightingale measures a broad group of biomarkers from a single blood sample, recognizing individual disease risks. The firm provides people with comprehensive insights on health, helps them make better decisions regarding their health and connects them with healthcare experts that offer preventative services for maintaining health. Nightingale Health Oy is the Parent Company in the Nightingale Group. The Group comprises the parent Company’s subsidiaries: Nightingale Health United States Inc, Nightingale Health Asia Pte Ltd, Nightingale Health Japan KK as well as NG Health Sweden AB. The firm owns and independently oversees two laboratories in Finland, in Helsinki and Kuopio, and one laboratory in Tokyo, Japan.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Nightingale Health Oyj is -393.4%, which is above its 3-year median of -440.3%.
Over the last 3 years, Nightingale Health Oyj’s Net Margin has increased from -695.7% to -393.4%. During this period, it reached a low of -695.7% on Jun 30, 2022 and a high of -346.1% on Dec 31, 2024.